For & Against

Claude View

What's Next

Sunteck's next three to six months hinge on two numbers and two approvals. The company reports quarterly pre-sales within weeks of quarter-end and full results a month later, so Q4 FY26 pre-sales (expected early April 2026) is the first real test of the ₹3,000 Cr full-year guide — 9M is at ₹2,093 Cr, which means Q4 must print ~₹900 Cr to hit the number. That is in line with Q4 FY25's ₹870 Cr "best-ever" quarter, but on a tougher comp and after a CMD who called the market "slightly fragile" in January.

No Results
Loading...

What the market will watch most closely: whether Q4 FY26 pre-sales print at ≥₹900 Cr and whether management upgrades or softens the "slightly fragile" framing on the Q4 call. Everything else — Dubai, the warrant math, the ₹60,000 Cr GDV roadmap — is secondary to that one quarterly data point.

For / Against / My View

For

Against

My View

Close call, slight edge to the bulls — but the edge is narrower than the 65–75% broker upside implies. The For side is held up by one concrete, near-dated mechanism (₹4,675 Cr of customer advances rolling into revenue) and one structurally rare asset (a net-cash Indian developer with a founder who owns two-thirds of the equity and takes his pay in stock appreciation). The Against side is held up by one aging narrative (Dubai + ₹60,000 Cr GDV) and one freshly-discovered risk (luxury concentration that the CMD himself flagged as fragile). I would lean constructive rather than bullish here — the balance sheet and credibility trajectory earn the benefit of the doubt, but I would wait for Q4 FY26 pre-sales to print at or above ₹900 Cr before sizing up, because that single number validates or kills the revenue-recognition catch-up thesis for the next four quarters. The one data point that would flip this view is a Q4 pre-sales miss coupled with any softening of Khetan's "slightly fragile" framing — that would turn the warrant dilution, the DII exit, and the re-levering into a coherent thesis-breaker rather than three loosely-connected concerns.